Manufacturing

Brazil Suspends 12 Million Doses of China’s Sinovac Vaccine

The Brazilian health regulator suspended the use of over 12 million doses of Chinese-made vaccines on Sept. 4 over being produced in an unauthorized plant, according to an official statement.

Brazil Suspends 12 Million Doses of Chinese COVID Vax

The Brazilian health regulator suspended the use of over 12 million doses of Chinese-made vaccines on Sept. 4 over being produced in an unauthorized plant, according to an official statement.

Biden’s Economy Created Just 235,000 Jobs in August

The U.S. economy added 235,000 jobs in August and the unemployment rate dipped to 5.2 percent, the Labor Department said in its monthly labor assessment Friday.

COVID Vax Contaminated with ‘Foreign Material’ that ‘Reacts to Magnets’: Japanese Health Ministry

1.6 million Moderna jabs halted after contaminants were discovered in vials.

Chinese Acquisition of Semiconductor Firm Poses Security Risks, US Treasury Warns

The U.S. Treasury Department said the sale of Magnachip Semiconductor Corp. to a Chinese private equity firm poses “risks to national security,” as Chinese investments in critical technologies meet with enhanced U.S. scrutiny.

Japan Pulls 1.6 Million Moderna Vaccines Over Contamination, Substance May Have Been Metal

"It's a substance that reacts to magnets," a Japanese Ministry of Health official said.

FDA Grants Full Approval of Pfizer Vaccine, Critics Blast Agency for Lack of Data, Scientific Debate

Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.

FDA Approves Pfizer’s COVID Vax

U.S. drug regulators on Monday approved the COVID-19 vaccine from Pfizer and BioNTech for people 16 and older, making it the first such shot to receive approval in the country.

Advanced Weapons Developer D.A.R.P.A. Invested $25M in Moderna’s mRNA Vax in 2013

The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million "to research and develop its messenger RNA therapeutics" nearly 8 years ago.

Latest news

- Advertisement -spot_img